Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Il controllo dell'infezione da HBV, HCV, HIV in emodialisi
Translated title of the contribution
:
Control of HCV, HBV and HIV Infections in Hemodialysis
Fabrizio Fabrizi
, Paul Martin
, Piergiorgio Messa
Dentistry
Icahn School of Medicine at Mount Sinai
Research output
:
Contribution to journal
›
Review article
›
peer-review
3
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Control of HCV, HBV and HIV Infections in Hemodialysis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Hemodialysis
100%
Human Immunodeficiency Virus Infection
100%
Dialysis Facility
100%
Infected Patients
75%
AIDS/HIV
50%
Dialysis
25%
Patient Management
25%
Hemodialysis Patients
25%
Clinical Practice Guidelines
25%
Chronic Kidney Disease
25%
Low Risk
25%
Immune Response
25%
Prospective Observational Study
25%
Vaccination
25%
Long-term Hemodialysis
25%
Special Circumstances
25%
Infection Control
25%
HBV Infection
25%
Regulatory Agencies
25%
Preventing Infection
25%
Maintenance Dialysis
25%
HBsAg-positive
25%
Isolation Method
25%
Industrialized World
25%
Hepatitis B Vaccine
25%
Blood-borne Pathogens
25%
Blood-borne Viruses
25%
HCV Transmission
25%
Dedicated Machines
25%
Medicine and Dentistry
Human Immunodeficiency Virus Infection
100%
Hemodialysis
100%
Hepatitis B Virus
100%
Infection
80%
Human Immunodeficiency Virus
40%
Pathogen
20%
Chronic Kidney Disease
20%
Observational Study
20%
Clinical Guideline
20%
Immune Response
20%
Hepatitis B Antigen
20%
Hepatitis B Vaccine
20%
Blood Borne Virus
20%
Immunology and Microbiology
Hepatitis B Virus
100%
Human Immunodeficiency Virus Infection
100%
Hemodialysis
100%
Infection
80%
Human Immunodeficiency Virus
40%
Immune Response
20%
HBsAg
20%
Hepatitis B Antigen
20%
Hepatitis B Vaccine
20%
Bloodborne Bacterium
20%
Blood Borne Virus
20%
Pharmacology, Toxicology and Pharmaceutical Science
Human Immunodeficiency Virus Infection
100%
Hemodialysis
100%
Hepatitis B Virus
100%
Infection
80%
HIV
40%
Observational Study
20%
Chronic Kidney Failure
20%
Hepatitis B Antigen
20%
Hepatitis B Vaccine
20%
Bloodborne Bacterium
20%
Nursing and Health Professions
Human Immunodeficiency Virus Infection
100%
Hemodialysis
100%
Infection
100%
Human Immunodeficiency Virus
50%
Chronic Kidney Failure
25%
Clinical Guideline
25%
Hepatitis B Antigen
25%
Dialysis Machine
25%
Hepatitis B Vaccine
25%